Viking Global Investors
Viking Global Investors, established in 1999, is a privately owned hedge fund sponsor with headquarters in Greenwich, Connecticut. It manages over $20 billion across long-short equity and long-only strategies, investing globally in public equity and fixed income markets. The firm employs fundamental analysis, utilizing both in-house and external research, to make strategic investments across diverse sectors. With additional offices in New York, Hong Kong, and London, Viking Global Investors provides services primarily to pooled investment vehicles.
Top Stages
Past deals in Connecticut
Rallybio
Series B in 2020
Rallybio is a clinical-stage biopharmaceutical company focused on developing therapies for severe and rare diseases. Its programs cover hematology, immuno-inflammation, maternal-fetal health and metabolic disorders, with a lead candidate aimed at preventing fetal and neonatal alloimmune thrombocytopenia, a life-threatening condition that can cause bleeding in fetuses and newborns. Founded in 2018 and based in New Haven, Connecticut, Rallybio develops therapies across antibodies, small molecules and engineered proteins to address unmet needs in rare diseases. Guided by experienced biopharma leadership, the company emphasizes translating biology into transformative therapies for underserved patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.